Biotech firms Redx Pharma and Jounce Therapeutics to combine business
23/02/2023 07:30
Feb 23 (Reuters) - British biotech firm Redx Pharma plc
REDX.L and U.S.-based Jounce Therapeutics Inc JNCE.O will
merge to create an entity specialised in small molecule-targeted
therapeutics and antibody drug discovery to treat cancer and
fibrotic disease.
The all-share merger deal will create a new company called
Redx Inc and will be listed on Nasdaq, the companies said on
Thursday.
(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sohini
Goswami)
((Radhika.Anilkumar@thomsonreuters.com;))